Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119292492 | 11929249 | 2 | F | 20160712 | 20160120 | 20160718 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-003088 | BRISTOL MYERS SQUIBB | 44.00 | YR | F | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119292492 | 11929249 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 20 MG, QD | 21436 | 20 | MG | TABLET | QD | ||||||
| 119292492 | 11929249 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 15 MG, QD | 21436 | 15 | MG | TABLET | QD | ||||||
| 119292492 | 11929249 | 3 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | 20 MG, QD | Y | 0 | 20 | MG | QD | ||||||
| 119292492 | 11929249 | 4 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Y | 0 | |||||||||||
| 119292492 | 11929249 | 5 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 119292492 | 11929249 | 6 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 119292492 | 11929249 | 7 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 119292492 | 11929249 | 8 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 119292492 | 11929249 | 9 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | U | 0 | |||||||||||
| 119292492 | 11929249 | 10 | C | TOPAMAX | TOPIRAMATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119292492 | 11929249 | 1 | Depression |
| 119292492 | 11929249 | 2 | Anxiety |
| 119292492 | 11929249 | 3 | Depression |
| 119292492 | 11929249 | 4 | Anxiety |
| 119292492 | 11929249 | 5 | Depression |
| 119292492 | 11929249 | 6 | Anxiety |
| 119292492 | 11929249 | 7 | Depression |
| 119292492 | 11929249 | 8 | Anxiety |
| 119292492 | 11929249 | 9 | Migraine |
| 119292492 | 11929249 | 10 | Migraine |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119292492 | 11929249 | Drug ineffective | |
| 119292492 | 11929249 | Panic attack | |
| 119292492 | 11929249 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119292492 | 11929249 | 3 | 201506 | 0 |